Medication Guide App

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Be a Responsible Camper

When you camp out, take steps to reduce your impact on the environment, experts advise. The nonprofit group Tread Lightly recommends using existing campsites whenever possible and camping on durable surfaces. Other ways to minimize your "footprint" include placing tents on non-vegetated areas, not digging trenches around tents, and camping at least...

Posted 3 days ago in New Drug Approvals

FDA Approves Raplixa (fibrin sealant [human]) to Control Bleeding During Surgery

The U.S. Food and Drug Administration today approved Raplixa (fibrin sealant [human]), the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery. Raplixa is a biological product approved for use in adults to help control bleeding from small blood vessels when standard surgical techniques, such...

Posted 3 days ago in New Drug Approvals

FDA Approves Breo Ellipta (fluticasone furoate/vilanterol) for Asthma

London, UK, and South San Francisco, CA, USA, 30 April 2015 – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is...

Posted 3 days ago in New Drug Applications

Amgen Announces FDA Advisory Committee Meeting to Review Repatha (Evolocumab) for High Cholesterol

Amgen (NASDAQ: AMGN) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) will review data supporting the Company's Biologics License Application (BLA) for Repatha (evolocumab) for the treatment of high cholesterol at a meeting on June 10, 2015. Repatha is an investigational...

Posted 2 days ago in Medical

Health Highlights: May 1, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Medicare Data Breaks Down Spending on Generics, Brand Name Drugs While generic medications are prescribed most often for Medicare patients, the most money is spent on brand name drugs, U.S. government data released Thursday shows. Experts think...

Posted 2 days ago in Medical

Health Tip: Spotting Signs of Urinary Tract Infection

-- A urinary tract infection (UTI) occurs when bacteria become prolific in the bladder, kidneys or elsewhere in the urinary tract. The National Kidney and Urologic Diseases Information Clearinghouse says symptoms of UTI may include: A burning sensation during urination. The frequent need to urinate, though often passing little urine. Pain in the...

Posted 2 days ago in Medical

Health Tip: Preventing Health Problems in Seniors

-- Preventive care can help diagnose potential health problems early, protecting you as you age. The American Academy of Family Physicians recommends: Getting regular vaccinations for flu and pneumonia. If you're a woman, getting breast cancer screening every two years, or as frequently as your doctor recommends. Regular colorectal cancer screening. Regular...

Posted 2 days ago in Pharma Industry News

Monthly News Roundup - April 2015

FDA Approves First-Time Generic for BMS’s Abilify Abilify (aripiprazole) is a blockbuster atypical antipsychotic drug used to treat the mental illnesses schizophrenia and bipolar disorder. On April 28th, the U.S. Food and Drug Administration (FDA) okayed the first generic versions of Abilify, which will save millions of dollars for patients and...

Posted 2 days ago in Medical

Routine Heart Care Similar From Nurse Practitioners, Doctors: Study

Many patients with chronic heart disease will receive the same quality of care from a nurse practitioner or physician assistant as they would from a doctor, a new study suggests. That's good news because the recent expansion of U.S. health coverage has many public health experts warning of a future with too few doctors for the patients on hand. "With...

Posted 2 days ago in Medical

When Restaurants Offer Healthy Kids' Fare, Children Eat It

Children ate healthier meals at a restaurant chain after the kids' menu got a makeover with healthy options replacing soda and fries, new research indicates. "Our study showed that healthier children's menu options were ordered a lot more often when those options were more prevalent and prominent on kids' menus, highlighting the promise of efforts...

Read more news...

Recently added consumer and prescribing information: Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web2)